xml version="1.0" ? dow-20220203

0001751788FALSE2021FY0000029915FALSE2021FY00017517882022-02-032022-02-030001751788dow:TheDowChemicalCompanyMember2022-02-032022-02-030001751788dow:TheDowChemicalCompanyMemberdow:A0500NotesDueMarch152027Member2022-02-032022-02-030001751788dow:A1125NotesDueMarch152032Memberdow:TheDowChemicalCompanyMember2022-02-032022-02-030001751788dow:TheDowChemicalCompanyMemberdow:A1875NotesDueMarch152040Member2022-02-032022-02-030001751788dow:A4625NotesDueOctober12044Memberdow:TheDowChemicalCompanyMember2022-02-032022-02-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

February 3, 2022 

[DATA_TABLE_REMOVED]

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

[DATA_TABLE_REMOVED]

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Dow Inc.☐The Dow Chemical Company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Dow Inc.☐The Dow Chemical Company☐

Section 8 - Other Events

Item 8.01 Other Events.

The documents listed below (the "Documents") are required to be filed as exhibits to Dow Inc. and The Dow Chemical Company Annual Report on Form 10-K (the "10‑K") for the year ended December 31, 2021. For administrative convenience and to avoid further increasing the size of the 10-K, the Company is filing the Documents as exhibits to this optional Current Report on Form 8-K and will incorporate the Documents into the 10‑K by reference hereto.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The exhibit listed on the Exhibit Index is incorporated herein by reference.

[DATA_TABLE_REMOVED]

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOW INC.

THE DOW CHEMICAL COMPANY

Date: February 3, 2022

/s/ RONALD C. EDMONDS

Ronald C. Edmonds

Controller and Vice President of Controllers and Tax